Plus Therapeutics Inc

NASDAQ:PSTV   3:59:47 PM EDT
2.09
-0.08 (-3.69%)
4:05:02 PM EDT: $2.09 0.00 (0.00%)
Products

Plus Therapeutics Receives Fast Track Designation From FDA For Its Novel Glioblastoma Treatment

Published: 09/15/2020 11:23 GMT
Plus Therapeutics Inc (PSTV) - Plus Therapeutics Receives Fast Track Designation From FDA for Its Novel Glioblastoma Treatment.